Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 232-240

  Tian, Fang ^a   Zhang, Caifeng ^b   Tian, Weihong ^c   Jiang, Yanan ^a   Zhang, Xiaoyan ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c Anyang Tumor Hospital   (China)

Author keywords

5 Fluorouracil; Curcumin; Esophageal squamous cell carcinoma; NF B signaling pathway; siRNA

Indexed keywords

CURCUMIN; FLUOROURACIL; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ACTIVATION; CELL FUNCTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SHAPE; CURCUMIN; CYTOPLASM; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, NUDE; NF-KAPPA B; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861535317     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1777     Document Type: Article

References (38)

1. Pisani P, Parkin DM, Bray F and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999. (Pubitemid 29409471)
2. Montesano R, Hollstein M and Hainaut P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 69: 225-235, 1996. (Pubitemid 26233303)
3. Chen FE and Ghosh G: Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 18: 6845-6852, 1999.
4. Pahl HL: Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-6866, 1999.
5. Guo K, Kang NX, Li Y, Sun L, Gan L, Cui FJ, Gao MD and Liu KY: Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 9: 100-110, 2009.
6. Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE and Schmitz F: Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 65: 37-45, 2003. (Pubitemid 36829089)
7. Liptay S, Weber CK, Ludwig L, Wagner M, Adler G and Schmid RM: Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer. Int J Cancer 105: 735-746, 2003. (Pubitemid 36706095)
8. Nair A, Venkatraman M, Maliekal TT, Nair B and Karimagaram D: NF-κB is constitutively activated in high-grade squamous intra-epithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22: 50-58, 2003. (Pubitemid 36152883)
9. Hannon GJ: RNA interference. Nature 418: 244-251, 2002.
10. Tuschl T and Borkhardt A: Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol Interv 2: 158-167, 2002.
11. Goel A, Kunnumakkara AB and Aggarwal BB: Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol 75: 787-809, 2008.
12. Tian F, Song M, Xu PR, Liu HT and Xue LX: Effect of siRNA-mediated inhibition of nuclear factor-κB in combination with 5-FU on apoptosis of squamous cell carcinoma cell lines. Shi Jie Hua Ren Xiao Hua Za Zhi 16: 1716-1721, 2008.
13. Tian F, Song M, Xu PR, Liu HT and Xue LX: Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-κB signaling pathway. Chin J Cancer 27: 566-570, 2008 (In Chinese).
14. Tian F, Fan TL, Jiang YN, Zhang XY and Wang XH: A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice. Pathol Res Pract 208: 32-38, 2012.
15. Tian F, Zang WD, Xu PR, Liu HT and Xue LX: Nuclear factor-kappaB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by siRNA. Acta Biochim Biophys Sin 38: 318-326, 2006.
16. Hou GQ, Zhang Q, Wang L, Liu M, Wang J and Xue LX: mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice. Cancer Lett 290: 248-254, 2010.
17. Bode AM and Dong Z: Signal transduction molecules as targets for cancer prevention. Sci Signal 2: mr2, 2009.
18. Prasad S, Ravindran J and Aggarwal BB: NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336: 25-37, 2010.
19. Sethi G, Ahn KS, Sung B and Aggarwal BB: Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol Cancer Ther 7: 1604-1614, 2008.
20. Sung B, Pandey MK and Aggarwal BB: Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation. Mol Pharmacol 71: 1703-1714, 2007. (Pubitemid 47010923)
21. Sethi G, Sung B and Aggarwal BB: Nuclear factor-κB activation: from bench to bedside. Exp Biol Med 233: 21-31, 2008.
22. Aota K, Azuma M, Yamashita T, Tamatani T, Motegi K, Ishimaru N, Hayashi Y and Sato M: 5-Fluorouracil induced apoptosis through the suppression of NF-κB activity in human salivary gland cancer cells. Biochem Biophys Res Commun 273: 1168-1174, 2000. (Pubitemid 30481097)
23. Tamatani T, Azuma M, Ashida Y, Motegi K, Takashima R, Harada K, Kawaguchi S and Sato M: Enhanced radiosensitization and chemosensitization in NF-κB-suppressed human oral cancer cells via the inhibition of γ-irradiation- and 5-FU-induced production of IL-6 and IL-8. Int J Cancer 108: 912-921, 2004. (Pubitemid 38112622)
24. Duffey DC, Chen ZH, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U and Van WC: Expression of a dominant-negative mutant inhibitor-κB of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 59: 3468-3475, 1999.
25. Zhou M, Gu LB, Zhu NX, Woods WG and Findley HW: Transfection of a dominant-negative mutant NF-κB inhibitor (IκBα) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IκBα and p53. Oncogene 22: 8137-8144, 2003. (Pubitemid 37487304)
26. Chi JT, Chang HY, Wang NN, Chang DS, Dunphy N and Brown PO: Genomewide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci USA 100: 6343-6346, 2003. (Pubitemid 36666583)
27. Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN and Fesik SW: Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 11: 6347-6352, 2003. (Pubitemid 36666584)
28. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G and Linsley PS: Expression profiling revealsoff-target gene regulation by RNAi. Nat Biotechnol 21: 635-637, 2003. (Pubitemid 36638089)
29. McMichael AJ: Food, nutrition, physical activity and cancer prevention. Authoritative report from World Cancer Research Fund provides global update. Public Health Nutr 11: 762-763, 2008.
30. Hong WK: General keynote: The impact of cancer chemoprevention. Gynecol Oncol 88: S56-S58, 2003.
31. Ermakova SP, Kang BS, Choi BY, Choi HS, Schuster TF, Ma WY, Bode AM and Dong Z: (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res 66: 9260-9269, 2006. (Pubitemid 44521148)
32. Aggarwal BB, Kumar A and Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398, 2003. (Pubitemid 36361976)
33. Li L, Aggarwal BB, Shishodia S, Abbruzzese J and Kurzrock R: Nuclear factor-κB and IκB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101: 2351-2362, 2004. (Pubitemid 39458693)
34. Pal S, Bhattacharyya S, Choudhuri T, Datta GK, Das T and Sa G: Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detec Prev 29: 470-478, 2005. (Pubitemid 41406143)
35. Tharakan ST, Inamoto T, Sung B, Aggarwal BB and Kamat AM: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem Pharmacol 79: 218-228, 2010.
36. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock R: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499, 2008.
37. Vadhan-Raj S, Weber D, Giralt S, Alexaman R, Thomas S, Zhou X, et al: Curcumin downregulates NF-κB and related genes in patients with multiple myeloma. Results of a phase 1/2 study. Blood 110: 1177, 2007.
38. Brenner H, Gondos A and Pulte D: Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level. Haematologica 93: 1544-1549, 2008.